AHCO vs TECH · P/E 16, rev $3.26B vs P/E 65, rev $1.22B
Adapthealth Corp (AHCO) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Adapthealth Corp (AHCO) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AHCO revenue for 2024-12-31 was $3.26B. Net income was $94.8M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. AHCO currently screens at market cap $1.26B and trailing P/E 16.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AHCO currently screens at market cap $1.26B and trailing P/E 16.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AHCO and TECH stock pages for the full models.
Not investment advice.